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Recovery from acute kidney injury involving tubular epithelial cells requires proliferation and migration of
healthy cells to the area of injury. In this study, we show that palladin, a previously characterized cytoskeletal
protein, is upregulated in injured tubules and suggest that one of its functions during repair is to facilitate
migration of remaining cells to the affected site. In a mouse model of anti-neutrophilic cytoplasmic antibody
involving both tubular and glomerular disease, palladin is upregulated in injured tubular cells, crescents and
capillary cells with angiitis. In human biopsies of kidneys from patients with other kidney diseases, palladin
is also upregulated in crescents and injured tubules. In LLC-PK1 cells, a porcine proximal tubule cell line,
stress induced by transforming growth factor-b1 (TGF-b1) leads to palladin upregulation. Knockdown of
palladin in LLC-PK1 does not disrupt cell morphology but does lead to a defect in cell migration.
Furthermore, TGF-b1 induced increase in the 75 kDa palladin isoform occurs in both the nucleus and the
cytoplasm. These data suggest that palladin expression is induced in injured cells and contributes to proper
migration of cells in proximal tubules, possibly by regulation of gene expression as part of the healing
process after acute injury.
A
cute kidney injury (AKI) is an abrupt reduction in kidney function with many possible causes, including
acute tubular necrosis (ATN). On the cellular level, the pathophysiology of ATN is complex: typically,
tubular epithelial cells lose polarity, brush borders are lost, membrane proteins are no longer appropri-
ately localized, the cytoskeleton is disrupted, and the tubular epithelial cells ultimately die and are shed into the
urine1,2. Long-term outcomes for patients with ATN are variable, and the factors that determine the ability of an
individual patient to recover are not well understood. In fact, there is a lack of agreement about the source of the
progenitor cells responsible for repair of tubules3,4. A better understanding of each step in the repair process is
necessary for the generation of prognostic biomarkers or therapeutic targets that can ameliorate the devastating
effects of AKI from ATN. Our study focuses on gaining insight into the process of kidney injury by studying the
function, expression and localization of palladin, a widely-expressed, cytoskeleton-associated protein that has
been implicated in the wound-healing process in multiple organs.
Palladin’s role in organized tissues has been explored using both a knockout mouse approach and an experi-
mental injury approach. Palladin is necessary for proper embryonic development, as the global knockout mouse
has an embryonic lethal phenotype and displays defects in body-wall closure5, a process that resembles wound-
healing in adults. In injury models, palladin is rapidly upregulated along the wound-edge in the brain, skin and
aorta of adult rodents6–8, implicating it in the process of tissue remodeling in these organs; however, palladin’s role
in kidney disease and injury has not yet been investigated. Previous work has shown that palladin is expressed in
multiple cell types in the adult, uninjured mammalian kidney, including smooth muscle cells, mesangial cells and
podocytes9.
Initial reports describing palladin’s expression and sub-cellular localization recognized three distinct palladin
isoforms10,11. Additional isoforms have since been identified, and the Universal Protein database now reports the
existence of nine variants with predicted molecular masses ranging from 43 to 150 kDa. These isoforms are
generated via differential splicing and alternative start-sites12; in addition, some cell types generate palladin size-
variants by post-translational regulated proteolysis13. Previous research has focused largely on the biological role
of isoform 4, and to a lesser extent on isoform 3, while the other isoforms have not been studied comprehensively.
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show that palladin isoform 4 is upregulated in injured or stressed
tubular epithelial cells and that palladin is required for appropriate
cell migration.
Results
Mouse Kidney Abundantly and Predominantly Expresses Palla-
din Isoform 4. Palladin was previously detected in the kidney using
the monoclonal antibody 1E6, which recognizes epitopes within a
proline-rich domain9 found only in isoforms 1, 3 and 4 (Figure 1). It
is now known that six additional palladin isoforms exist that are not
detected by 1E6. To test whether any of the more recently described
isoforms of palladin are expressed in the kidney, we utilized two
previously characterized pan-palladin polyclonal antibodies (621
and 622)14,15, as well as an antibody (PALL75) targeting a domain
contained in isoforms 1, 3 and 4, which provides more consistently
reliable results than 1E6. Specificity of PALL75 was tested by
immunoblot analysis of previously characterized human pancreatic
carcinoma-associated fibroblasts16. PALL75 detected a robust 75 kDa
band, the predicted size of isoform 4, in WT cells and only low levels
of this band in the cells in which isoform 4 has been stably knocked
down with shRNA (Figure 2A). Of note, in previous work from our
lab and others, this band ran at a higher molecular weight, ,90 kDa.
This was thought to be due to the presence of proline-rich regions in
certain isoforms. With newer gel systems, this isoform is now running
closer to its predicted MW of 75 kDa. Immunoblots of lysates of
whole mouse kidney with 621 and PALL75 demonstrated that
isoform 4 is the major palladin variant in the kidney, although a
number of other bands which may be lower prevalence variants
were also detected (Figure 2B). These results are consistent with
previous studies showing that palladin isoform 4 protein9 and
mRNA17 are abundant in the adult mammalian kidney.
Multiple Cell Types Within the Kidney Express Palladin. Immu-
nohistochemical (IHC) staining of adult mouse kidney sections using
the pan-palladin antibody 622 was performed to investigate palladin
expression at the cellular level. Low-magnification image (Figure 2C)
showed higher levels of palladin expression in the cortex compared to
medulla. At higher magnification (Figure 2D), smooth muscle cells
and podocytes were palladin-immunopositive, consistent with
previously published results9. Palladin was also detected in tubular
and parietal epithelial cells, which had not been demonstrated
previously. IHC with PALL75 revealed that palladin was robustly
detected in podocytes and smooth muscle cells (Figure 2, E–G),
and also detected in tubular and parietal epithelial cells,
confirming the results obtained with the pan-palladin antibody.
Palladin Expression is Altered in Multiple Models of Kidney
Injury. To investigate the pattern of palladin expression following
injury to the kidney, an in vivo mouse model and biopsy specimens
from human kidney disease as well as in vitro models of injury were
utilized. First, palladin expression was investigated using a mouse
model of an autoimmune disease that generates chronic injury in
the kidney. The a-myeloperoxidase (a-MPO) model of anti-
neutrophilic cytoplasmic antibody (ANCA) histologically exhibits
both glomerular and tubulointerstitial injury after disease
induction by splenocyte transfer18. Animals were examined at 4, 8,
12, 16 and 19 days after transfer. Two animals were stained from each
time point. Four days after transfer, there was no significant
glomerular disease activity as assessed by the absence of crescents
(Supplemental Figure 1), although tubular injury was already
apparent. Twelve days after splenocyte transfer, significant disease
activity was observed in the glomerular compartment with active
cellular crescents and in the tubular compartment with necrosis,
dilation and vacuolization of tubular cells. By day 16, some tubules
had healed and crescents were more fibrocellular.
Expression of palladin in injured tubular cells, as assessed by semi-
quantitative scoring by a blinded pathologist, increased as severity of
injury increased. By day 16, in healed tubules, palladin levels
Figure 1 | Nine palladin isoforms. The nine currently identified palladin isoforms and structural domains encompassed by each. Blue boxes denote Ig
domains and green boxes denote proline-rich domains with specific proline-rich sequences as indicated. An arrow marks the region used to develop the
antibody that recognizes isoforms 1, 3 and 4 using genomic antibody technology (PALL75). Map is adapted from UniProt sequences and utilizes UniProt
nomenclature for human palladin isoforms, which exhibits some differences with NCBI, both in nomenclature and sequences of some isoforms.
Predicted molecular weights (in kDa) are indicated.
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returned to near baseline. In the glomerular compartment, cellular
crescents present at day 12 expressed high levels of palladin. As
crescents became more fibrous than cellular with deposition of extra-
cellular matrix, palladin levels in crescents decreased (Figure 3A). In
the vascular compartment, peritubular capillaries, which do not
express palladin in wild type mice and 4 days after splenocyte trans-
fer, began expressing palladin in the peritubular capillaries 12 days
after injury that partially resolved by day 16 (Figure 3B). Thus,
expression of palladin correlated closely with disease activity in this
model system in three different compartments. Interestingly, others
have previously shown at the mRNA level that palladin is down-
regulated in human focal segmental glomerulosclerosis (FSGS)9.
One possibility for this discrepancy from our findings can be
explained by a difference in mRNA expression and protein express-
ion. Additionally, the cell types involved in each type of kidney
disease will affect palladin expression levels differently.
The increase in expression of palladin in the mouse model of
disease led us to examine its expression and cellular localization in
human patients. Biopsy samples exhibiting both tubular and glom-
erular injury were examined. The arterionephrosclerosis section
includes the vascular compartment in which smooth muscle cells
and endothelial cells are positive. The tubular and glomerular com-
partments do not show active disease. The tubular compartment is
mostly negative, although distal tubules are faintly positive. The
glomerular compartment is positive in podocytes and parietal epi-
thelial cells (PECs) but negative in mesangial cells. The ANCA sec-
tion exhibits crescents and tubular injury. Crescents are intensely
positive, and injured tubular cells are also positive. The Lupus section
also has crescents, which are intensely positive. The tubular com-
partment is not injured, and the cells are negative. The anti-glom-
erular basement membrane (GBM) section also has positively
staining crescents and an injured tubular compartment, which is
positive. A normal glomerulus is also shown in this section
(Figure 3C). As in the mouse model of ANCA, palladin expression
in tubules increased in proportion to disease severity, and in three
different crescentic diseases, palladin was consistently expressed
within crescents. In three ATN patients with non-immunologic kid-
ney disease, expression of palladin in tubular epithelial cells increased
with severity of injury (Figure 3D).
Due to the abundance of isoform 4 in the kidney by immunoblot
and the increase in palladin expression in the a-MPO mouse model
and human kidney diseases, we examined whether isoform-specific
upregulation of palladin isoforms may be a common cellular res-
ponse to cytokines associated with inflammation and injury, regard-
less of cell type. To address this question, we utilized a commonly
used cell-culture model to study the response of proximal tubule
cells to injury. Immunoblot analysis revealed that LLC-PK1 cells,
derived from the kidney proximal-tubule, express modest levels of
isoform 4 at baseline, similar to levels of expression as observed by
IHC staining of normal tissue. However, when LLC-PK1 cells were
treated with TGF-b1, isoform 4 levels increased after 2 days of
exposure (Figure 4A).
Figure 2 | Validation of PALL75 and palladin isoforms in mouse and human tissue. PALL75 recognizes predominantly a band ,75 kDa which is
knocked down in stable knockdown lines from human cancer-associated fibroblasts, on which we have previously published and designated shRNA1 and
shRNA216. A less intense band at ,130 kDa is also present, which probably represents isoform 3. Although predicted MW of isoform 3 is ,108 kDa, it
actually runs at ,130 kDa as confirmed by mass spectrometry of excised 130 kDa band in a human cell line (data not shown). GAPDH shown for loading
control (A). Different isoforms in mouse and human kidney. Proteins extracted from kidneys of wild type mice and human were immunoblotted with
antibodies to palladin. One representative sample (B). 621 detects isoform 4 most robustly. Other bands are present which may represent lower-
prevalence variants. PALL75 detects isoform 4 most robustly. Immunohistochemical staining of C57BL/6 wild type mouse kidney with 622 (C, D) and
PALL75 (E, F). Vessels are shown with asterisks (*)as palladin is known to be present in smooth muscle cells. Arrows denote podocytes. Arrowheads
denote proximal tubule cells. No primary antibody control (G).
www.nature.com/scientificreports
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Epithelial-to-mesenchymal transition (EMT) refers to the phe-
nomenon of transformation of a cell from an epithelial to a mesench-
ymal phenotype. TGF-b1 is a known mediator of EMT. Previous
studies have shown that EMT in LLC-PK1 cells is triggered more
effectively by the combined treatment of TGF-b1 together with dis-
ruption of the cells’ adherens junctions19. Reducing cell confluence or
lowering the concentration of Ca11, combined with TGF-b1 treat-
ment modeled this ‘‘two hit’’ treatment. Results show a synergistic
increase in expression of isoform 4 (Figure 4B).
Because IHC revealed strong expression in glomerular cells,
expression of isoform 4 was also examined in an immortalized mouse
podocyte line. Isoform 4 was expressed at baseline in podocytes,
consistent with IHC results, and treatment of cultured podocytes
with TGF-b1 led to a greater than 50% increase in isoform 4 express-
ion (Figure 4, C and D). Interestingly, a slight increase in expression
is also seen in a band ,120 kDa, detected by both 621 and PALL75,
which is presumed to be isoform 3.
Palladin Knock Down Does Not Change Morphology of LLC-
PK1. Results from mouse and human kidneys showed that palla-
din is upregulated in response to injury; in pig cells in culture, the
primary isoform upregulated is isoform 4, suggesting that isoform 4
could play a role in the morphological remodeling that occurs after
injury. To investigate the role of palladin in morphologic remodeling,
palladin was transiently knocked down in LLC-PK1 cells using two
different siRNAs (4P1 and 4P2) targeted to isoform 4 (Figure 5A).
Fluorescence imaging of control and knockdown cells revealed no
obvious morphological differences in the actin cytoskeleton in the
palladin knockdown cells (Figure 5, B–D). The ability of knockdown
cells to respond to TGF-b1 with the characteristic increase in abun-
dance and assembly of stress fibers was examined. Surprisingly,
knockdown of palladin had no effect on either actin cytoskeleton
organization (Figure 5, E–G) or a-smooth muscle actin (a-SMA)
protein expression (Figure 5H), a commonly used marker of myo-
fibroblasts, indicating that palladin does not contribute to TGF-b1-
dependent stress fiber formation in LLC-PK1 cells.
Knockdown of Palladin Delays Wound-Healing In Vitro. Because
palladin has previously been shown to play a role in migration of a
fibroblast cell line5 and vascular smooth muscle cells20, and because
cell migration is required for healing after AKI, we hypothesized that
palladin also participates in the migration of tubular epithelial cells. To
address this question, we performed a scratch-wound assay in which a
wound is introduced into a confluent monolayer of epithelial cells then
observed as the remaining cells migrate to refill the artificial wound.
Knockdown of palladin in LLC-PK1 cells led to a significant defect in
cell migration along the wound edge compared to control (Figure 6 and
supplemental videos). Despite our previous results showing that palladin
is not required to maintain normal actin organization, these results
indicate that it is important in epithelial cell migration in vitro,
suggesting a distinct molecular function in this cell type.
Palladin Isoform 4 is Present in the Nucleus. An alternative way
that palladin may affect cell migration is by regulating gene
Figure 3 | Palladin expression in a-MPO model of ANCA and human kidney diseases. IHC staining of mouse kidney cortex with 622 and PALL75 (A)
show an increase in palladin expression in tubules and crescents as disease progresses from 4 days up to 12 days after disease induction. Sections from
medulla show an increase in staining in the vasa recta of the medulla with intensity parallel to disease severity (B). Palladin expression in human biopsy
specimens. IHC staining of biopsy sections from different human kidney diseases with PALL75 (C). Arrows denote podocytes; arrowheads denote
proximal tubule cells; double-headed arrows denote distal tubule cells; (*) denote smooth muscle cells; C denotes crescents. IHC staining of three patients
with non-immunologic mediated kidney injury and ATN with PALL75 (D).
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expression. Palladin has been shown to localize to the nucleus in a
variety of cells types, and to regulate gene expression in vascular
smooth muscle cells9,21. To assess whether palladin could play a
similar role in kidney epithelial cells, palladin’s subcellular localiza-
tion was probed by immunoblot analysis of fractionated LLC-PK1
cells. Isoform 4 was detected in both the cytoplasm and the nucleus at
baseline, and its levels increased in both compartments following
treatment with TGF-b1 (Figure 7). This novel observation in this
cell type is consistent with a model of direct or indirect gene
regulation by palladin isoform 4.
Discussion
Palladin is a multi-domain, actin-binding protein that is widely
expressed in mammalian organs, including the kidney.9,17 It has an
unusual molecular niche, as it binds directly to both F-actin and
multiple other actin-binding proteins, suggesting that it may func-
tion as an actin-binding scaffold protein10–12,20,22–27. In addition to
binding actin, it is also a regulator of gene expression21,28, as well as
the activity of two different Rho-family GTPases, Rac 1 and Cdc42,
both of which play critical roles in actin organization16,29. Palladin
also binds directly to multiple proteins that are key regulators of actin
dynamics, including profilin22, VASP23, ezrin11, Lasp-112, EPS829,
CLP-3626, and a-actinin24,25. For these reasons, much of the scientific
literature to date has focused on palladin’s role in organizing actin-
based structures, including the invadopodia found in tumor-assoc-
iated fibroblasts and breast cancer cells16,30; stress fibers, lamellipodia
and focal adhesions in mouse embryonic fibroblasts31; podosomes
and dorsal ruffles in vascular smooth muscle cells29; and the axonal
growth cone in cortical neurons32. In addition, previous work impli-
cated palladin (isoforms 3 and 4 in dermal fibroblasts, and isoform 4
in smooth muscle cells and astrocytes) in the process of wound
healing, as specific palladin isoforms are rapidly upregulated at sites
of injury to the brain8, aorta20, and skin7.
Although previous studies have documented the expression of
palladin isoform 4 in smooth muscle cells, podocytes and mesangial
cells of the kidney9, this is the first report documenting palladin
expression in other kidney cell types, including endothelial cells,
parietal epithelial cells and tubular epithelial cells. Furthermore,
our study is the first to examine palladin expression in diseased or
injured kidneys. Our results obtained with IHC staining of mouse
and human kidney sections, taken together with results obtained
using cultured kidney epithelial cells, suggest that palladin plays a
role in the healing process after acute kidney injury.
It is well established that LLC-PK1 cells undergo EMT in vitro in
response to TGF-b133–35, a commonly accepted mediator of tubu-
lointerstitial fibrosis. In a previous study of palladin’s role in skin
injury, dermal fibroblasts were shown to upregulate the expression of
palladin isoforms 3 and 4 following treatment with TGF-b17.
Similarly, we observed an increase in isoform 4 expression in LLC-
PK1 cells treated with TGF-b1 with a slight increase in isoform 3.
Based on palladin’s role in organizing the actin cytoskeleton in other
cell types5,10,20,32,36, we expected that knocking down palladin in LLC-
PK1 would lead to alterations in actin organization both before and
after TGF-b1 treatment, but surprisingly, we did not observe any
Figure 4 | Increased palladin isoform 4 expression in immortalized proximal tubule epithelial cells, LLC-PK1, and podocytes in response to stress.
LLC-PK1 cells were treated for two days with TGF-b1 and lysed. Cell lysates were run on Western Blot (A). Detection with 621 shows several different
isoforms present in the tubular cells with the most significant change in isoform 4. PALL75 also detects an increase in isoform 4 expression (A). GAPDH is
shown for loading control. Isoform 4 expression is increased further in a double stress model with TGF-b1 and low calcium media (B). a-tubulin is
shown for loading control. Differentiated immortalized mouse podocytes were treated for two days with TGF-b1, lysed and run on Western Blot (C).
Detection with 621 shows several different isoforms. Isoform 4 is present at baseline and increases by 55% with TGF-b1 treatment by densitometric
analysis (D). When blotted with PALL75, the increase in isoform 4 expression is also seen and confirmed by densitometric analysis (C and D). GAPDH is
shown for loading control.
www.nature.com/scientificreports
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changes in actin organization in the palladin knockdown cells, sug-
gesting that palladin does not play an essential role in the morpho-
logical changes that occur with EMT.
Despite these unexpected results, our in vivo findings in the a-
MPO mouse model and human kidney biopsies suggest a potential
role for palladin in the kidney’s response to injury, as expression
correlated positively with disease severity. As palladin has been
shown to play a role in the migration of smooth muscle cells20, breast
cancer cells30, and tumor-associated fibroblasts in culture16, we
hypothesized that isoform 4 could play a critical role in the migration
of tubular epithelial cells following injury. Although the origin of
these regenerating tubular cells is still under debate3,4, migration is
part of the process of healing in the injured kidney1,2,37 regardless of
the nature of the cells, and this process shares attributes with
development, where palladin is known to have a role. Thus, a defect
in migration would delay healing from acute tubular injury. Scratch-
wound assays demonstrated that palladin was indeed necessary for
appropriate migration in vitro. Of note, we were unable to specifically
target isoform 4 for knockdown as it is completely embedded in
isoforms 1 and 3, so we were unable to rule out a contribution from
either of these lesser prevalent isoforms. Indeed, isoform 4 is most
highly upregulated in our cell culture model, although isoform 3 also
shows a slight increase in expression. One interpretation of this
finding is that after acute injury, upregulation of palladin isoform(s)
is an essential step in the migratory process that allows epithelial cells
to move to areas of denuded basement membrane where they regain
polarity and re-establish a viable epithelial layer.
There is a growing body of evidence supporting a sub-population
of tubular epithelial cells, called scattered tubular cells, that have
the capacity to regenerate in response to acute kidney injury.
Astonishingly, these cells share similar markers (CD133 and CD24)
and protein expression patterns with PECs3,38. The expression pattern
of palladin in tubular epithelial cells after injury and PECs suggests
that it may be another marker of this cell type, although its presence
in other cell types limits its specificity. Both cell types migrate, either
to the site of injury as with scattered tubular cells, or to the glomerular
crescent, as is proposed in crescentic glomerular diseases.
If indeed palladin plays a role in migration and in differentiation of
smooth muscle cells21 as others have shown, this leads to the question
of whether palladin is more than just a scaffolding protein. Palladin
contains no nuclear import signals, but it does contain a nuclear
export signal and has been shown in both podocytes and differen-
tiated smooth muscle cells to accumulate in the nucleus when nuclear
export is blocked with leptomycin B9,21. In addition, recent studies
showed specific point mutations at sites of actin binding, which led to
nuclear localization39. A co-immunoprecipitation assay showed
binding to myocardin-related transcription factors (MRTFs), and
imaging colocalized palladin to MRTFs21 in differentiated smooth
muscle cells. Furthermore, knock down of palladin in these cells
altered expression of proteins contributing to their contractile prop-
erties36. Our results showed that an increase in nuclear expression of
isoform 4 also occurs in a stress model in vitro. Although further
investigation is required, this finding suggests palladin may play a
role in gene regulation.
Figure 5 | Palladin knock down does not show change in stress fiber formation in response to TGF- b1. Western blot confirms efficient transient
knockdown of isoform 4 with siRNA (A) in LLC-PK1 cells. GAPDH shown for loading control. LLC-PK1 cells were exposed to either control scrambled
RNA sequence (CONsi) or siRNA targeted to palladin isoform 4 (4P1 and 4P2), then fixed and stained with phalloidin. Untreated CONTROL, 4P1 and
4P2 cells (B–D). CONTROL, 4P1 and 4P2 treated with TGF-b1 (E–G). Western blot shows that the knockdown cells express a-SMA when treated with
TGF-b1 (H).
www.nature.com/scientificreports
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One limitation of this study is the correlative nature of our find-
ings. Disease-induced increases in palladin expression could be
either protective or harmful. Findings by scratch assay suggest a
protective role, but this hypothesis cannot be confirmed without
an in vivo knockout, which poses a unique challenge as the global
knockout of all palladin isoforms is embryonic lethal and cannot be
used for functional studies. The presence of multiple isoforms with
overlapping regions also makes developing certain isoform-specific
knockouts a challenging endeavor. In addition, expression in mul-
tiple cell types necessitates multiple cell-specific knockouts.
However, determining palladin’s function in the injured kidney will
shed insight into its role as a potential therapeutic target.
Figure 6 | Scratch wound assay shows defect in migration in palladin deficient cells. LLC-PK1 cells transfected with control scrambled sequence, 4P1 or
4P2 were subjected to scratch-wound assay. Initial and final images are shown for control sequence (A and B), 4P1 (C and D) and 4P2 (E and F). Data from
five separate scratch assays were aggregated from both the palladin knock down cells and the cells transfected with control scrambled sequence. Linear
regression lines represent the amount of closure determined from each time point (G). The slope represents the rate of closure of each individual scratch
point for CON, 4P1 and 4P2 (H). Each dot represents one scratch point analyzed. *P50.0019 for CON vs. 4P1; and **P50.0001 for CON vs. 4P2.
www.nature.com/scientificreports
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Additionally, regardless of whether it contributes to or prevents
injury, if the level of palladin expression in tubular epithelial cells
correlates with disease severity as suggested by IHC, it also has
potential as a biomarker. Future studies to assess whether palladin
increases in tubular cells shed into the urine during episodes of AKI
could provide a useful, non-invasive tool for diagnosis and prognosis
of AKI.
In summary, our study is the first to show an increase in palladin
expression in the kidney in different cell types of each compartment
(tubular, glomerular and vascular) and in different diseases, suggest-
ing a role for palladin in pathogenesis of kidney disease of various
etiologies. In addition, our in vitro studies suggest that palladin may
have a protective role in the tubular compartment as it is necessary
for proper migration. Further understanding of the precise role of
palladin in kidney disease will help advance knowledge of the patho-
genesis of AKI and reveal a role for palladin as a therapeutic target or
biomarker.
Methods
Cell Lines. The kidney proximal tubule cell line, LLC-PK1 from ATCC (ATCC# CL-
101) has been previously characterized as having properties of kidney proximal tubule
cells40,41. Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin. For
serum starvation, cells were grown in DMEM supplemented with 0.5% FBS and
penicillin/streptomycin 12–18 hours prior to the experimental protocol. All cell lines
were maintained at 37uC with constant 5% carbon dioxide.
The heat sensitive mouse podocyte line was a kind gift from Dr. Stuart Shankland
and maintained in RPMI containing 10% FBS and sodium pyruvate (Gibco, Grand
Island, NY) and maintained as described42. Cells were held in proliferation stage at
33uC with interferon-c (Roche, Indianapolis, IN) and temperature switched to 37uC
to induce differentiation 10–12 days prior to cell lysis.
Animal Model. The mouse model of antineutrophilic cytoplasmic autoantibody
(ANCA) specific for myeloperoxidase (MPO) was previously published18 and is
referred to here as a-MPO. In brief, a-MPO knockout mice received MPO injection,
with initial priming intraperitoneal injection of 10 ug followed by boosters at days 21
and 36. They were given a final 10 ug intravenous injection four days prior to transfer
of 1 3 108 a-MPO splenocytes from these animals to recombinase-activating gene-2
(Rag2) deficient mice which lack functioning B and T lymphocytes. Animals were
sacrificed at 4, 8, 12, 16 and 19 days after splenocyte transfer. Severe necrotizing and
crescentic glomerulonephritis developed. Kidneys were fixed in 10% formalin and
sectioned for staining. Animal studies were performed under protocols in accordance
with relevant guidelines and regulations and approved by the Institutional Review
Board of the University of North Carolina at Chapel Hill.
Antibodies. The following antibodies were used: palladin monoclonal 1E6 (Novus
Biologicals, Littleton, CO, USA); GAPDH (GeneTex, San Antonio, TX, USA and
Santa Cruz Biotechnology, Dallas, TX, USA); a-smooth muscle actin (Abcam,
Cambridge, MA, USA); a-tubulin (Thermo-Scientific, Rockford, IL, USA); a-lamin
A/C (Sigma Aldrich, St. Louis, MO, USA) and palladin polyclonals 621 and 622.
These antibodies were generated by immunizing rabbits with multiple fusion proteins
representing N-terminal, central and C-terminal fragments of palladin isoform 1. 621
performed optimally on western blots, and 622 performed optimally in
immunohistochemical staining, and were used accordingly. HRP-conjugated
secondary antibodies were obtained from Jackson Immunoresearch (West Grove,
PA, USA). IR dye secondary antibodies were obtained from LICOR (Lincoln, NE,
USA).
A polyclonal antibody directed to specific target sequences from full-length human
palladin was generated using genomic antibody technology by SDIX (Newark, DE,
USA). DNA sequence from the target region of amino acids 713–802, including one of
the proline-rich regions, was incorporated into DNA to allow for native folding of the
epitope of interest and is referred to here as PALL75 (Figure 1).
siRNA Knockdown. The following siRNA were used in this study
(sense strands): 4P1 (59 AGGUGAAGCUGAAGCAUUAUU 39) and 4P2
(59 CCGAAGAUCUACUGGUUUAUU 39). Their target sequences are contained in
isoforms 1, 3 and 4. siCONTROL Non-Targeting siRNA #2 was obtained from
Dharmacon (Lafayette, CO). Cells were transfected using the TransIT siQuest
transfection reagent (Mirus, Madison, WI) following manufacturer’s instructions.
Briefly, 6 ml of transfection reagent was added to 250 ml serum-free media per 1.5 ml
of final volume of media. To this mixture, the appropriate volume of siRNA was
added to achieve a final concentration of 40 nM and incubated for 15 minutes at
room temperature then added drop-wise to cells. Cells were assayed between 48 to
72 hours post transfection.
Cell Culture. Cells were seeded in 6 well plates and serum-starved overnight prior to
treatments. Cells were either treated with TGF-b1 (R&D Systems, Minneapolis, MN,
USA) at a final concentration of 4 ng/mL or carrier. After the designated time period,
cells were lysed for immunoblot, and cover slips were fixed for immunofixation.
Scratch-Wound Assay. LLC-PK1 cells were exposed to siRNA KD or control
scrambled sequence for 48–96 hours and cultured to confluence in 6 well plates.
When confluent, scratches were made with a sterile 200 mL pipette tip, intersecting at
the center of the well. Each well was washed 3x with 1x PBS. Media was replaced on
the cells and the plate was placed on an Olympus IX70 microscope in an incubator
maintained at 37u C with constant CO2. Cells were imaged at 10x every 5 minutes for
24 hours using Volocity software and a Hammatsu ORCA C4742-95 camera. The
rate of scratch closure was determined using Tscratch software developed by the
Koumoutsakos group (CSE Lab, ETH Zürich43).
Student’s t-tests were used for comparing the means of the rate of closure of scratch
wounds from five different experiments between cells transfected with control-
scrambled sequence and the two transiently knocked down cells lines, 4P1 and 4P2.
Cell and Tissue Lysis and Immunoblot. Cells cultured on 6 well, 60 mm or 100 mm
tissue culture dishes were washed with 1x PBS then scraped into a lysis buffer
containing 1x PBS, 1% Triton X-100, and protease inhibitor cocktail (Thermo
Scientific, Rockford, IL, USA). Supernatant was collected after centrifugation at 14
500 rpm for 15 min at 4uC and analyzed by immunoblot. For the immunoblot,
lysates were boiled in 5X Laemmli buffer for 4 minutes, and 20–30 mg of protein were
resolved by SDS-PAGE in each lane of a 4–15% gel then transferred to nitrocellulose
and immunoblotted. Immunocomplexes were visualized using the Immobilon
Chemiluminescence HRP Detection kit (Millipore, Billerica, MA, USA) or the
Odyssey Imaging System for LICOR secondary antibodies (Lincoln, NE, USA).
Kidney tissue was snap-frozen in liquid nitrogen, ground with a chilled mortar and
pestle, and extracted in lysis buffer containing 50 mM Tris pH 7.5, 8 M urea, 5% SDS,
10 mM EDTA, and protease inhibitor cocktail. Samples were then centrifuged at 14
500 rpm for 15 min at 4uC to remove any insolubilized particulates, and the super-
natant was resolved by SDS-PAGE in a 4–15% gel, using 20 mg protein per lane.
Proteins were transferred to nitrocellulose and immunoblotted and visualized as
above.
Immunofluorescence. Cells were grown on glass coverslips and fixed in 4%
paraformaldehyde in PBS for 7 minutes, then permeabilized in 0.2% Triton X-100 for
2 minutes, blocked with normal goat serum for one hour and incubated with
phalloidin to stain actin. Coverslips were examined with a Nikon TE2000 microscope
Figure 7 | Nuclear fractionation of palladin isoform 4. Whole cell and fractionated lysates of LLC-PK1 cells treated with TGF-b1. Blot with 621(A) and
PALL75 (B) shows an increase in isoform 4 expression in whole cell lysates (W) and in both cytoplasmic (C) and nuclear (N) compartments. Lamin
and a-tubulin blots confirm fractionation (C).
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with 20x and 60x objective lenses, and a Hamamatsu Orca-ER camera. Images were
acquired and analyzed with Metamorph software.
Immunohistochemistry. De-identified patient samples of kidney biopsy cores
were obtained through an Institutional Review Board (IRB)-exempt study
supported through the Nephropathology Department. The study was reviewed by
the University of North Carolina IRB and determined to be exempt from
continuing review. Experiments were conducted in accordance with relevant
guidelines and regulations. Mouse kidney was prepared as above. Ten total mice
were stained, two at each time point of 4, 8, 12, 16 and 19 days post splenocyte
transfer. IHC was carried out in the Bond fully-automated slide staining system
(Leica Microsystems Inc. Norwell, MA, USA). Slides were deparaffinized in Bond
Dewax solution (AR9222) and hydrated in Bond Wash solution (AR9590).
Antigen retrieval was performed for 30 min at 100uC in Bond-epitope retrieval
solution 1 pH 6.0 (AR9961). After pretreatment, the primary antibodies 622 and
PALL75 were applied for 0.5 and 1 hour, respectively. Detection of PALL75 was
performed using the Bond Intense R Detection System (DS9263) supplemented
with the goat anti-Rabbit-HRP (EnVision1, DAKO, Carpinteria, CA, USA) and
Bond Polymer Refine Detection System (DS9800) for 622. Stained slides were
dehydrated and cover-slipped. Positive and negative controls (no primary
antibody) were included for each antibody. Stained slides were digitally imaged at
203 magnification using the Aperio ScanScope XT (Aperio Technologies, Vista,
CA, USA). Digital images were stored in the Aperio Spectrum Database.
Intensity of palladin staining was scored by a blinded pathologist on a semi-
quantitative scale (neg, trace, 11, 21, 31). Severity of tubular injury was also
assessed by a blinded pathologist on a semi-quantitative scale (normal, mild,
moderate and severe) based on the following criteria: loss of brush border,
simplification, dilation, irregularity of tubules and denudation of the epithelial
cells.
Nuclear/Cytoplasmic Fractionation. Cells were fractionated by first incubating in
hypotonic buffer (1 M Hepes, pH 7.9; 1 M MgCl2; 1 M KCl; 100 mM DTT; 100 mM
Na3VO4; 0.5 M EDTA with protease inhibitors) on ice for 20 minutes followed by
centrifugation at high speed at 4uC to extract the cytoplasmic fraction. The pellet was
washed once with hypotonic buffer and once with PBS. This was followed by a 20-
minute incubation on ice with a high salt buffer (1 M Hepes, pH 7.9; 1 M NaCl; 1 M
MgCl2; 100 mM DTT; 100 mM Na3VO4; 0.5 M EDTA, 50% glycerol with protease
inhibitors) and centrifugation at high speed at 4uC to extract the nuclear fraction.
Fractionation was confirmed with immunoblot expression of a-tubulin for
cytoplasmic and a-lamin A/C for nuclear fraction.
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